Target Step Stool Recall Issued Due to Reports of Injuries

|

A recall has been issued by Target for more than 200,000 wooden step stools sold at stores throughout the United States, after dozens of consumers have reportedly fallen when the step stool collapsed under their weight.

The Target step stool recall was announced on Thursday by the U.S. Consumer Product Safety Commission, indicating that at least 26 reports have been received by Target of the stools breaking or collapsing.

Several of the falls caused by the defective Target stools have resulted in serious injuries, including at least two adults who suffered a fractured wrist, one of which also fractured her hip and pelvis. At least 14 of the incidents involved children, with many resulting in scrapes and bruising.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The recalled Target stools were sold under the Circo and “Do Your Room” brand names, coming in a variety of colors, including natural wood, natural and red, white and honey.

Each of the step stools contain two steps, with the Circo stools featuring storage under a lid on the bottom step and the “Do Your Room” stool featuring a lid on the top step that lifts to provide storage.

The stools were sold between January 2007 and October 2010 for between $25 and $30.

Consumers have been advised to immediately stop using the recalled step stools and return them to Target for a full refund.


0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Nitrous oxide injury lawsuits are emerging as medical evidence links recreational use of the gas to nerve damage that can cause numbness, balance problems and difficulty walking, often without adequate side effect warnings.
A federal judge has scheduled a series of Bard PowerPort trials between April 2026 and February 2027, which will focus on allegations that defective design flaws made the devices susceptible to infections, fractures and migration.
A federal judge is calling for dozens of attorneys to reapply for leadership positions in Depo-Provera brain tumor litigation before their appointments expire in March.